India’s biotech startup ecosystem is seeing growing interest in combining artificial intelligence with advanced genetic engineering, as companies look to develop new tools for agriculture and healthcare.

Bengaluru-based Mandrake Bio, founded in 2025 by Masters’ Union University student Tanay Lohia and ICAR scientist Dr Kutubuddin Molla, is developing what it describes as an AI-driven platform for designing gene-editing enzymes. The startup recently raised about Rs 16 crore ($1.9 million) in a pre-seed funding round co-led by Activate and Antler India, according to the startup.

The round also saw participation from Spectrum Impact, DeVC and angel investors. The company plans to use the funds to expand its AI and biophysics teams and increase laboratory validation of its designs.

Mandrake Bio said its approach differs from conventional gene-editing research, which often works with naturally occurring systems such as CRISPR-Cas9. Its platform uses generative AI, protein language models trained on metagenomic data, structural biology and computational biophysics to design new gene-editing enzymes.

The company is initially focusing on agriculture, including crops that could require fewer inputs and better withstand climate-related stresses. It also plans to apply the technology to genetic medicines, with a business model based on co-developing frontier applications in partnership with pharma companies and licensing its developed molecular technologies to seed companies and drug developers.

Lohia said the company’s approach reflects a shift towards designing biological tools rather than only identifying naturally occurring ones. “This is the chapter where we start writing biology, not just reading it.”

According to a 2026 BCG report, biotech startups in India have increased to about 2,400, while private equity and venture capital investment in the sector reached $731 million in FY26.

Separately, IBEF data shows the number of registered biotech startups in India rose to 11,855 in 2025, from 10,075 a year earlier. The government has also allocated ₹3,446 crore to the Department of Biotechnology under the 2026-27 Budget, including ₹2,300 crore for the Bio-RIDE programme.

Against this backdrop, Masters’ Union is equipping the next generation of builders and leaders to contribute to India’s growing biotech ecosystem, with students exploring and building ventures at the intersection of science, technology and entrepreneurship.